BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16624822)

  • 21. S100A7, Jab1, and p27
    Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
    J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The crucial p53-dependent oncogenic role of JAB1 in osteosarcoma in vivo.
    Samsa WE; Mamidi MK; Bashur LA; Elliott R; Miron A; Chen Y; Lee B; Greenfield EM; Chan R; Danielpour D; Zhou G
    Oncogene; 2020 Jun; 39(23):4581-4591. PubMed ID: 32390003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stabilization of p53 in human cytomegalovirus-initiated cells is associated with sequestration of HDM2 and decreased p53 ubiquitination.
    Chen Z; Knutson E; Wang S; Martinez LA; Albrecht T
    J Biol Chem; 2007 Oct; 282(40):29284-95. PubMed ID: 17698841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of p53 activity by Siva1.
    Du W; Jiang P; Li N; Mei Y; Wang X; Wen L; Yang X; Wu M
    Cell Death Differ; 2009 Nov; 16(11):1493-504. PubMed ID: 19590512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.
    Ahn J; Hong SA; Lee SE; Kim J; Oh YS; Park SJ; Chung YJ
    Endocr J; 2009; 56(5):707-13. PubMed ID: 19461157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSN5/Jab1 controls multiple events in the mammalian cell cycle.
    Yoshida A; Yoneda-Kato N; Panattoni M; Pardi R; Kato JY
    FEBS Lett; 2010 Nov; 584(22):4545-52. PubMed ID: 20974137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation.
    Migliorini D; Danovi D; Colombo E; Carbone R; Pelicci PG; Marine JC
    J Biol Chem; 2002 Mar; 277(9):7318-23. PubMed ID: 11744695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hdm2 nuclear export, regulated by insulin-like growth factor-I/MAPK/p90Rsk signaling, mediates the transformation of human cells.
    Jackson MW; Patt LE; LaRusch GA; Donner DB; Stark GR; Mayo LD
    J Biol Chem; 2006 Jun; 281(24):16814-20. PubMed ID: 16621805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear β-catenin expression is positively regulated by JAB1 in human colorectal cancer cells.
    Nishimoto A; Takemoto Y; Saito T; Kurazumi H; Tanaka T; Harada E; Shirasawa B; Hamano K
    Biochem Biophys Res Commun; 2020 Dec; 533(3):548-552. PubMed ID: 32977947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
    Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N
    Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The oncoprotein SS18-SSX1 promotes p53 ubiquitination and degradation by enhancing HDM2 stability.
    D'Arcy P; Maruwge W; Ryan BA; Brodin B
    Mol Cancer Res; 2008 Jan; 6(1):127-38. PubMed ID: 18234968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of nuclear and cytoplasmic degradation of p53 in cells after stress.
    Joseph TW; Moll UM
    Methods Mol Biol; 2003; 234():211-7. PubMed ID: 12824534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair.
    Tian L; Peng G; Parant JM; Leventaki V; Drakos E; Zhang Q; Parker-Thornburg J; Shackleford TJ; Dai H; Lin SY; Lozano G; Rassidakis GZ; Claret FX
    Oncogene; 2010 Nov; 29(46):6125-37. PubMed ID: 20802511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Jab1, a novel protease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activator protein-1.
    Luo W; Wang Y; Hanck T; Stricker R; Reiser G
    J Biol Chem; 2006 Mar; 281(12):7927-36. PubMed ID: 16410250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas.
    Wang Y; Fei M; Cheng C; Zhang D; Lu J; He S; Zhao Y; Wang Y; Shen A
    Cancer Biol Ther; 2008 Mar; 7(3):460-7. PubMed ID: 18285702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific domains of nucleolin interact with Hdm2 and antagonize Hdm2-mediated p53 ubiquitination.
    Bhatt P; d'Avout C; Kane NS; Borowiec JA; Saxena A
    FEBS J; 2012 Feb; 279(3):370-83. PubMed ID: 22103682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.
    Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R
    J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.
    Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J
    Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction.
    Medina-Medina I; Martínez-Sánchez M; Hernández-Monge J; Fahraeus R; Muller P; Olivares-Illana V
    Protein Sci; 2018 May; 27(5):976-986. PubMed ID: 29524278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.
    Nie L; Sasaki M; Maki CG
    J Biol Chem; 2007 May; 282(19):14616-25. PubMed ID: 17371868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.